BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29322835)

  • 1. Toxic epidermal necrolysis versus cutaneous Graft-Versus-Host Disease in a hematopoietic stem cell transplant recipient: the role of elafin.
    Chen A; Chao K; Rodriguez L; Munday W; Worswick S
    Leuk Lymphoma; 2018 Sep; 59(9):2261-2263. PubMed ID: 29322835
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft-vs-host Disease and Toxic Epidermal Necrolysis Following Hematopoietic Stem Cell Transplantation.
    Vera N; Lewis S; Seminario-Vidal L
    Cutis; 2022 Feb; 109(2):E9-E12. PubMed ID: 35659813
    [No Abstract]   [Full Text] [Related]  

  • 3. [Case report; differential diagnosis of post-transfusion graft-versus-host disease in a case with toxic epidermal necrolysis].
    Ohyagi H; Kume M; Takahashi N; Sawada K
    Nihon Naika Gakkai Zasshi; 2013 Jun; 102(6):1467-9. PubMed ID: 23947216
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxic Epidermal Necrolysis vs. Acute Cutaneous Graft Versus Host Disease after Hematopoietic Stem Cell Transplantation: A Diagnostic and Therapeutic Challenge.
    Rodríguez Tejero A; Badiola González J; Roldán Mateo L; Molina Leyva A
    Actas Dermosifiliogr (Engl Ed); 2021 Jan; 112(1):81-82. PubMed ID: 32986973
    [No Abstract]   [Full Text] [Related]  

  • 5. Delayed presentation of toxic epidermal necrolysis-like cutaneous acute graft-versus-host disease in the setting of recent immunosuppressant discontinuation.
    Goyal PKK; Xu S; Choi J
    Dermatol Online J; 2017 Oct; 23(10):. PubMed ID: 29469783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive toxic epidermal necrolysis versus acute graft versus host disease after allogenic hematopoietic stem-cell transplantation: challenges in diagnosis and management.
    Macedo FI; Faris J; Lum LG; Gabali A; Uberti JP; Ratanatharathorn V; White MT
    J Burn Care Res; 2014; 35(6):e431-5. PubMed ID: 24476990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic epidermal necrolysis-like acute cutaneous graft-versus-host disease in a stem cell recipient - a diagnostic dilemma.
    Klein B; Kolm I; Nair G; Nägeli MC
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e585-e587. PubMed ID: 33914967
    [No Abstract]   [Full Text] [Related]  

  • 8. Graft-versus-host disease or toxic epidermal necrolysis: diagnostic dilemma after liver transplantation.
    Jeanmonod P; Hubbuch M; Grünhage F; Meiser A; Rass K; Schilling MK; Kollmar O
    Transpl Infect Dis; 2012 Aug; 14(4):422-6. PubMed ID: 22650490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic epidermal necrolysis-like acute graft-versus-host disease in pediatric bone marrow transplant patients: Case series and review of the literature.
    Sheu Song J; Huang JT; Fraile Alonso MDC; Antaya RJ; Price HN; Funk T; Francois RA; Shah SD
    Pediatr Dermatol; 2022 Nov; 39(6):889-895. PubMed ID: 35730149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical markers for histopathological diagnosis and differentiation of acute cutaneous graft-versus-host disease.
    Wegner J; Weidenthaler-Barth B; Engelbert J; Knothe M; Braun C; Helbig D; Sacher C; Kreft A; Wagner EM; Ziemer M; Meyer RG; von Stebut E
    Exp Dermatol; 2021 Dec; 30(12):1814-1819. PubMed ID: 34223669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic epidermal necrolysis and graft vs. host disease: a clinical spectrum but a diagnostic dilemma.
    Stone N; Sheerin S; Burge S
    Clin Exp Dermatol; 1999 Jul; 24(4):260-2. PubMed ID: 10457124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of tissue elafin as an immunohistochemical marker for diagnosis of acute skin graft-versus-host disease: a pilot study.
    Mahabal GD; George L; Peter D; Bindra M; Thomas M; Srivastava A; Mathews V; George B; Pulimood SA
    Clin Exp Dermatol; 2019 Mar; 44(2):161-168. PubMed ID: 29882232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic epidermal necrolysis in a child 6 months post-hematopoietic stem cell transplantation.
    Oba U; Yamada H; Suenobu SI; Nakamura Y; Ito A; Hatano Y; Itonaga N; Ohshima K; Koga Y; Ohga S; Ihara K
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28497658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited utility of plasma elafin as a biomarker for skin graft-versus-host disease following allogeneic stem cell transplantation.
    George L; Mahabal G; Mohanan E; Balasubramanian P; Peter D; Pulimood S; Lakshmi K; Jeyaseelan L; Abraham A; Srivastava A; Mathews V; George B
    Clin Exp Dermatol; 2021 Dec; 46(8):1482-1487. PubMed ID: 34081805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease.
    Brüggen MC; Petzelbauer P; Greinix H; Contassot E; Jankovic D; French L; Socié G; Rabitsch W; Kuzmina Z; Kalhs P; Knobler R; Stingl G; Stary G
    J Invest Dermatol; 2015 Apr; 135(4):999-1006. PubMed ID: 25405322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study comparing histological and immunophenotypic patterns in stage 4 skin graft vs host disease from toxic epidermal necrolysis.
    Naik H; Lockwood S; Saavedra A
    J Cutan Pathol; 2017 Oct; 44(10):857-860. PubMed ID: 28626936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A preliminary study on clinical diagnostic value of plasma elafin in skin acute graft-versus-host disease].
    Luo CW; Weng JY; Wu SJ; Lu ZS; Guo R; Du X
    Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):922-5. PubMed ID: 23363749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome in a hematopoietic stem cell transplant recipient.
    Birch J; Chamlin S; Duerst R; Jacobsohn D
    Pediatr Blood Cancer; 2008 Jun; 50(6):1278-9. PubMed ID: 18260119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal calprotectin in allogeneic stem cell transplantation for the diagnosis of acute intestinal graft versus host disease.
    Bastos Oreiro M; Castilla-Llorente C; de la Guía AL; de Paz R; Van Domselaar M; Nieto J; Rodriguez A; Gallardo D; Canales M;
    Bone Marrow Transplant; 2012 Sep; 47(9):1241-2. PubMed ID: 22307017
    [No Abstract]   [Full Text] [Related]  

  • 20. CD8+ lymphocytes in the blister fluid of severe acute cutaneous graft-versus-host disease: further similarities with toxic epidermal necrolysis.
    Correia O; Delgado L; Barbosa IL; Domingues JC; Azevedo R; Vaz CP; Pimentel P
    Dermatology; 2001; 203(3):212-6. PubMed ID: 11701973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.